Coya Therapeutics earnings were -$20.3M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest COYA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$6.1M, down 16.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, COYA reported annual earnings of -$14.9M, with 86.3% growth.
What were Coya Therapeutics's earnings last quarter?
On COYA's earnings call on Invalid Date, Coya Therapeutics (NASDAQ: COYA) reported Q2 2025 earnings per share (EPS) of -$0.36, up 89.47% year over year. Total COYA earnings for the quarter were -$6.09 million. In the same quarter last year, Coya Therapeutics's earnings per share (EPS) was -$0.19.
As of the last Coya Therapeutics earnings report, Coya Therapeutics is currently losing money. Coya Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$20.34 million, a 101.38% increase year over year.
What was COYA's earnings growth in the past year?
As of Coya Therapeutics's earnings date in Invalid Date, Coya Therapeutics's earnings has grown year over year. COYA earnings in the past year totalled -$20.34 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.